Your browser doesn't support javascript.
loading
Health-related quality of life in patients with relapsed/refractory multiple myeloma treated with pomalidomide and dexamethasone ± subcutaneous daratumumab: Patient-reported outcomes from the APOLLO trial.
Terpos, Evangelos; Dimopoulos, Meletios A; Boccadoro, Mario; Delimpasi, Sosana; Beksac, Meral; Katodritou, Eirini; Moreau, Philippe; Pompa, Alessandra; Symeonidis, Argiris; Bila, Jelena; Oriol, Albert; Mateos, Maria-Victoria; Einsele, Hermann; Orfanidis, Ioannis; Gries, Katharine S; Fastenau, John; Liu, Kevin; He, Jianming; Kampfenkel, Tobias; Qiu, Yanping; Amin, Himal; Carson, Robin; Sonneveld, Pieter.
Afiliación
  • Terpos E; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.
  • Dimopoulos MA; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.
  • Boccadoro M; Department of Molecular Biotechnology and Health Sciences, University of Torino, Turin, Italy.
  • Delimpasi S; Department of Hematology, Evangelismos Hospital, Athens, Greece.
  • Beksac M; Department of Hematology, Ankara University, Ankara, Turkey.
  • Katodritou E; Department of Hematology, Theagenio Cancer Hospital, Thessaloniki, Greece.
  • Moreau P; Hematology Department, University Hospital Hôtel-Dieu, Nantes, France.
  • Pompa A; Hematology Unit, University of Milan, Milan, Italy.
  • Symeonidis A; Department of Internal Medicine, University of Patras, Patras, Greece.
  • Bila J; Clinic of Hematology, University of Belgrade, Belgrade, Serbia.
  • Oriol A; Institut Català d'Oncologia, Hospital Germans Trias I Pujol, Barcelona, Spain.
  • Mateos MV; Hematology Department, University Hospital of Salamanca/IBSAL/Cancer Research Center-IBMCC (USAL-CSIC), Salamanca, Spain.
  • Einsele H; Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany.
  • Orfanidis I; Health Data Specialists S.A., Dublin, Ireland.
  • Gries KS; Janssen Research & Development, LLC, Seattle, Washington, USA.
  • Fastenau J; Janssen Research & Development, LLC, Raritan, New Jersey, USA.
  • Liu K; Janssen Research & Development, LLC, Raritan, New Jersey, USA.
  • He J; Janssen Research & Development, LLC, Raritan, New Jersey, USA.
  • Kampfenkel T; Janssen Research & Development, LLC, Leiden, Netherlands.
  • Qiu Y; Janssen Research & Development, LLC, Beijing, China.
  • Amin H; Janssen Research & Development, LLC, Raritan, New Jersey, USA.
  • Carson R; Janssen Research & Development, LLC, Wayne, Pennsylvania, USA.
  • Sonneveld P; Department of Hematology, Erasmus University Medical Center Cancer Institute, Rotterdam, Netherlands.
Am J Hematol ; 97(4): 481-490, 2022 04.
Article en En | MEDLINE | ID: mdl-35089607
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Mieloma Múltiple Límite: Humans Idioma: En Revista: Am J Hematol Año: 2022 Tipo del documento: Article País de afiliación: Grecia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Mieloma Múltiple Límite: Humans Idioma: En Revista: Am J Hematol Año: 2022 Tipo del documento: Article País de afiliación: Grecia